NO822171L - Viricide alfa,alfa-dialkyl adamantyletylaminer. - Google Patents

Viricide alfa,alfa-dialkyl adamantyletylaminer.

Info

Publication number
NO822171L
NO822171L NO822171A NO822171A NO822171L NO 822171 L NO822171 L NO 822171L NO 822171 A NO822171 A NO 822171A NO 822171 A NO822171 A NO 822171A NO 822171 L NO822171 L NO 822171L
Authority
NO
Norway
Prior art keywords
alfa
adamantyletylamines
viricide
dialkyl
herpes
Prior art date
Application number
NO822171A
Other languages
English (en)
Norwegian (no)
Inventor
Ronald Conrad Griffith
Clyde Richard Kinsolving
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO822171L publication Critical patent/NO822171L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO822171A 1981-06-26 1982-06-25 Viricide alfa,alfa-dialkyl adamantyletylaminer. NO822171L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/277,777 US4351847A (en) 1981-06-26 1981-06-26 Antiviral alpha, alpha-dialkyl adamantylethylamines

Publications (1)

Publication Number Publication Date
NO822171L true NO822171L (no) 1982-12-27

Family

ID=23062307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822171A NO822171L (no) 1981-06-26 1982-06-25 Viricide alfa,alfa-dialkyl adamantyletylaminer.

Country Status (13)

Country Link
US (1) US4351847A (de)
EP (1) EP0068365B1 (de)
JP (1) JPS5841817A (de)
AT (1) ATE23148T1 (de)
AU (1) AU551678B2 (de)
CA (1) CA1172170A (de)
DE (1) DE3273975D1 (de)
DK (1) DK287282A (de)
FI (1) FI822282L (de)
IE (1) IE53460B1 (de)
IL (1) IL65787A (de)
NO (1) NO822171L (de)
ZA (1) ZA823699B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537908A (en) * 1981-06-26 1985-08-27 Pennwalt Corporation Herpes II treatment
US4386105A (en) * 1982-02-19 1983-05-31 Pennwalt Corporation Use of alpha, alpha-dialkyl adamantylethylamines to treat measles
US5506231A (en) * 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
US5334618A (en) * 1991-04-04 1994-08-02 The Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5614560A (en) * 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
WO1992017168A1 (en) * 1991-04-04 1992-10-15 The Children's Medical Center Corporation Method of preventing nmda receptor-mediated neuronal damage
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
WO2017127306A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamatane derivatives for the treatment of filovirus infection
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
JP2026520211A (ja) 2023-06-16 2026-06-22 ハイデルべルク イミュノセラピューティクス ゲーエムベーハー 新規の抗hsv抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3352912A (en) * 1963-07-24 1967-11-14 Du Pont Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes
US4100170A (en) * 1967-12-18 1978-07-11 Pennwalt Corporation Anorectic adamantane derivatives and method of using the same

Also Published As

Publication number Publication date
EP0068365A1 (de) 1983-01-05
AU551678B2 (en) 1986-05-08
IE821258L (en) 1982-12-26
IL65787A (en) 1985-05-31
FI822282A7 (fi) 1982-12-27
IE53460B1 (en) 1988-11-23
DK287282A (da) 1982-12-27
ATE23148T1 (de) 1986-11-15
IL65787A0 (en) 1982-08-31
ZA823699B (en) 1983-05-25
US4351847A (en) 1982-09-28
JPS5841817A (ja) 1983-03-11
EP0068365B1 (de) 1986-10-29
DE3273975D1 (de) 1986-12-04
AU8441382A (en) 1983-01-06
CA1172170A (en) 1984-08-07
FI822282L (fi) 1982-12-27
FI822282A0 (fi) 1982-06-24

Similar Documents

Publication Publication Date Title
DE3065420D1 (en) Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours
GEP19970949B (en) Antiemetic and tranquilizing agent for prevention of sea sickness
ES8502117A1 (es) Un procedimiento para preparar derivados de purina.
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
EP0135312B1 (de) Antivirale Zusammensetzungen
FI823871L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
AU551678B2 (en) Antiviral alpha alpha dialkyl adamantylethylamines
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
IE832255L (en) Treatment of herpes labialis.
US4720379A (en) Use of dimercaptopropanesulfonic acid and dimercapto-propanesuccinic acid for the preparation of pharmaceutical compositions and a method of treatment
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
ES8503649A1 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos
DE3365954D1 (en) The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles
ES8303299A1 (es) Procedimiento de preparacion de un nuevo derivado de acido benzamido-alquil-hidroxamico.
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS5663918A (en) Antitumorigenic agent containing siomycin half ester
GB1211387A (en) 0-benzylpiperidine derivative and a process for the preparation thereof
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
JPS55149213A (en) Remedy of dna for viral disease
ES8105724A1 (es) Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos
Al-Khayat et al. Some studies on the effects of ambilhar on mobilisation and excretion of lead
IE35338L (en) 6-deoxy-5-oxytetracycline-5-esters
DE3316611A1 (de) Antivirusmittel
DE1807733A1 (de) Basisches Wismutinosithexaphosphat